Revolutionising drug discovery with deep learning
Revolutionising drug discovery with deep learning
Europe PMC and Open Targets develop Lit-OTAR framework unearthing over 48 million unique associations that can be leveraged for drug discovery Identifying drug targets is a critical and intricate part of drug discovery. This requires scientists to look at many sources of evidence. They use them to find links between drugs, targets, and diseases. This […]
Introducing Europe PMC Annotated Full-text Corpus for bioentities and associations
Introducing Europe PMC Annotated Full-text Corpus for bioentities and associations
Europe PubMed Central (Europe PMC) is an open access repository of life science research, including peer-reviewed journal articles and preprints. It contains over 41 million abstracts and 8.7 million full-text articles, adding over 1.7 million new articles annually. To facilitate information discovery and foster literature–data integration, Europe PMC has incorporated text-mining approaches into its workflows. […]
Europe PMC in 2020: a year review
Europe PMC in 2020: a year review
The year 2020 was marked by the global COVID-19 pandemic and the Europe PMC team, like many others around the world, started to work from home. Scientific literature is at the heart of scientific research and during these extraordinary times, Europe PMC worked on improving existing services, building new features, increasing the full text content […]
Partnerships & funding
Europe PMC is a service of the Europe PMC Funders' Group, in partnership with EMBL’s European Bioinformatics Institute (EMBL-EBI); and in cooperation with the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NCBI/NLM) . It includes content provided to the PubMed Central (NLM/PMC) archive by participating publishers.
